Recombinant Mouse IL4RA Protein
Cat.No. : | IL4RA-8174M |
Product Overview : | Recombinant Mouse IL4RA full length or partial length protein was expressed. |
- Specification
- Gene Information
- Related Products
Source : | Mammalian Cells |
Species : | Mouse |
Tag : | His |
Form : | Liquid or lyophilized powder |
Endotoxin : | < 1.0 EU per μg of the protein as determined by the LAL method. |
Purity : | >80% |
Notes : | This item requires custom production and lead time is between 5-9 weeks. We can custom produce according to your specifications. |
Storage : | Store it at +4 ºC for short term. For long term storage, store it at -20 ºC~-80 ºC. |
Storage Buffer : | PBS buffer |
Gene Name : | Il4ra interleukin 4 receptor, alpha [ Mus musculus ] |
Official Symbol : | IL4RA |
Gene ID : | 16190 |
mRNA Refseq : | NM_001008700.3 |
Protein Refseq : | NP_001008700.1 |
MIM : | |
UniProt ID : | P16382 |
Products Types
◆ Recombinant Protein | ||
IL4RA-2703R | Recombinant Rat IL4RA Protein, His (Fc)-Avi-tagged | +Inquiry |
Il4ra-75M | Recombinant Mouse Il4ra Protein, His (Fc)-Avi-tagged | +Inquiry |
Il4ra-332M | Recombinant Mouse Il4ra Protein, His-tagged | +Inquiry |
Il4ra-333M | Recombinant Mouse Il4ra Protein, Fc-tagged | +Inquiry |
IL4RA-3048R | Recombinant Rat IL4RA Protein | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (6)
Ask a questionIl4ra is mainly used for treatment, and it has not been reported that it can be used to prevent disease.
The safety of Il4ra has not been adequately studied in pregnant or lactating women and should be used with caution.
Mechanism of action of Il4ra is to regulate the immune response by inhibiting the Il4 signaling pathway.
The production process and quality control of Il4ra require strict compliance with relevant regulations and standards, including Good Manufacturing practice (GMP), to ensure their safety and effectiveness.
The length of treatment for Il4ra depends on the nature of the disease and the patient's response to treatment, and generally lasts from several weeks to several months.
There are a number of clinical trials underway for recombinant Il4ra, which have shown some efficacy in the treatment of asthma, autoimmune diseases, etc.
Customer Reviews (3)
Write a reviewEasy to use, high stability, remarkable effect.
Good application performance in immune detection, such as ELISA, western blot and so on.
High synthesis efficiency and yield.
Ask a Question for All IL4RA Products
Required fields are marked with *
My Review for All IL4RA Products
Required fields are marked with *
Inquiry Basket